| NCT ID | NCT06566950 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Udayana University |
| Condition | Blood Flow Restriction Training |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2024-09-20 |
| Primary Completion | 2024-11-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 75 participants in total. It began in 2024-09-20 with a primary completion date of 2024-11-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized clinical trial study compares high-load eccentric training (HL-Et), sham LL-BFRt, and low-load blood flow restriction (LL-BFRt) in sportsmen. The primary inquiries it seeks to address are: Is LL-BFR superior to HL-Et and sham LL-BFRt in terms of improving muscle morphology? Is LL-BFR a more effective Patellofemoral Pain Syndrome and ACL injury preventive than HL-Et and sham LL-BFRt? The three intervention groups that will be randomly assigned to participants are LL-BFRt, sham LL-BFRt, and HL-Et. Participants are expected to carry out: Participants in LL-BFRt will be required to perform LL eccentric training at 30% of their repetition maximum (RM) and 70% of their artery occlusion pressure (AOP). This training will include stairs, single leg squat, and single leg deadlift. Participants in HL-Et will be required to perform LL eccentric training at 70% of their maximum number of repetitions (RM). In order to determine whether muscular morphology and the prevention of Patellofemoral Pain Syndrome and ACL injury improve following the interventions and follow-up, researchers will compare LL-BFRt, sham LL-BFRt, and HL-Et.
Eligibility Criteria
Inclusion Criteria: * Being between the ages of 15 and 35 * Play level 1 sports (fight martial arts, basketball, futsal, and soccer) at least twice a week * Never experienced an Patellofemoral Pain Syndrome or ACL injury before * Never experienced a grade III sprain or strain * Consent to participate in the study until its conclusion and provide informed consent. Exclusion Criteria: * Having a tumor, cancer, vena thromboembolic disease, obesity, diabetes, hypertension, anemia, and renal failure * Disabilities or those who are disabled.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06566950 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 35 Years, studying Blood Flow Restriction Training. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06566950 currently recruiting?
Yes, NCT06566950 is actively recruiting participants. Contact the research team at surya_adhitya@unud.ac.id for enrollment information.
Where is the NCT06566950 trial being conducted?
This trial is being conducted at Denpasar, Indonesia.
Who is sponsoring the NCT06566950 clinical trial?
NCT06566950 is sponsored by Udayana University. The trial plans to enroll 75 participants.